ダウンロード数: 637
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
59_453.pdf | 884.45 kB | Adobe PDF | 見る/開く |
タイトル: | 下部尿路症状を伴う限局性膀胱アミロイドーシスにDMSO膀胱内注入療法が奏功した1例 |
その他のタイトル: | Effectiveness of DMSO Intravesical Therapy for Lower Urinary Symptoms of Primary Amyloidosis Localized in the Urinary Bladder : A Case Report |
著者: | 川崎, 芳英 方山, 博路 加藤, 愼之介 |
著者名の別形: | Kawasaki, Yoshihide Katayama, Hiromichi Kato, Shinnosuke |
キーワード: | Localized bladder amyloidosis LUTS DMSO intravesical therapy |
発行日: | Jul-2013 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 59 |
号: | 7 |
開始ページ: | 453 |
終了ページ: | 456 |
抄録: | Primary amyloidosis localized in the urinary bladder is comparatively rare, and 40% of the patients complain of lower urinary tract symptoms (LUTS). Although standard management for amyloidosis localized in the urinary bladder is not established, transurethral resection (TUR) is performed in most of the cases to diagnose the disease and to control bleeding. TUR is not considered as radical therapy for amyloidosis localized in the urinary bladder because of frequent recurrence. Dimethyl sulfoxide (DMSO) administered through intravenous, percutaneous or intravesical route has been shown to be effective for treating and preventing recurrence of the disease, but its effect on LUTS due to amyloidosis localized in the urinary bladder has not been demonstrated. We report a case showing improvement of LUTS and in which recurrence of amyloidosis localized in the urinary bladder was prevented for 18 months by intravesical DMSO therapy. |
著作権等: | 許諾条件により本文は2014-08-01に公開 |
URI: | http://hdl.handle.net/2433/177499 |
PubMed ID: | 23945328 |
出現コレクション: | Vol.59 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。